• search
For Quick Alerts
For Daily Alerts

Biomarkers' ability to improve prediction of heart risk minimal, say experts

By Super Admin

Washington, July 1 (ANI): Researchers from Massachusetts General Hospital have revealed that measuring the known biomarkers modestly improves the prediction of future heart attack, but not enough to change preventive therapies.

Although conventional risk factors - like as smoking, hypertension, cholesterol levels and age - can identify individuals at the highest risk for heart attack or stroke, many people without these factors still experience these potentially devastating events.

"While there currently does not appear to be a role for routine use of biomarkers in screening for cardiovascular risk, our data do not exclude a role for biomarkers in selected patients," said Dr. Thomas Wang, of the MGH Heart Centre, the study's senior and co-corresponding author.

"We're still optimistic that new technologies will lead to the discovery of biomarkers that could help us move toward offering truly personalized cardiovascular risk prediction," he added.

The current study was focused on two biomarkers that have been extensively studied in cardiovascular disease - C-reactive protein (CRP) and N-terminal pro-B-type natriuretic peptide (N-BNP) - and four that recently have been identified as relating to cardiovascular risk - Cystatin C, Lp-PLA2, MR-proADM and MR-proANP.

The researchers found that two of the studied biomarkers - N-BNP and MR-proADM - did significantly improve the prediction of coronary events, defined as a heart attack or death from ischemic heart disease.

N-BNP and C-reactive protein improved the prediction of cardiovascular events, which are coronary events plus strokes.

But when the ability of biomarkers to move individual patients into higher- or lower-risk categories was analysed, the potential impact on treatment decisions was minimal.

"Since choice of therapies may depend on the risk category a patient falls into, moving patients between risk categories could lead to a change in therapy," said co-author Dr. Christopher Newton-Cheh, of MGH Heart Centre.

"While there was more category movement among participants initially classified as intermediate-risk, that resulted primarily from movement to lower risk levels, so we still need to find biomarkers that can make a clinically significant difference in predicting cardiovascular risk" he added.

The study appears in the Journal of the American Medical Association. (ANI)

For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more